Cited by 114Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Aggravation of epilepsy by anti-epileptic drugs

Open access

Gayatri, NA, Livingston, JH·2006·Developmental Medicine & Child Neurology

DOI 10.1017/s0012162206000843

Open this paper in CoChat — free account Open PDF

Abstract

The possibility that so‐called anti‐epileptic drugs (AEDs) may aggravate epilepsy must always be borne in mind by the clinician. Many reports of such aggravation of seizures have been published. Most such reports are anecdotal and speculative, and suggest that many such reactions are idiosyncratic. However, for some there is a sufficient body of evidence to suggest that some AEDs used in certain epilepsies may consistently cause worsening of seizures. Seizure aggravation may include increase in the frequency or severity of existing seizures, emergence of new types of seizure, or the occurrence of status epilepticus. The pathophysiology of seizure aggravation is poorly understood including nonspecific effects such as those associated with sedation, druginduced encephalopathy, and paradoxical or inverse pharmacodynamic effects. For some epilepsies the choice of AEDs may be inappropriate, and although the mechanism of seizure aggravation is not clear, its occurrence may be fairly predictable. This is best documented for the use of carbamazepine in idiopathic generalized and myoclonic epilepsies. Most other AEDs have been reported occasionally to cause seizure aggravation. The lowest risk of seizure aggravation appears to be with valproate. Risk factors for worsening of seizures are epileptic encephalopathy, polytherapy, high frequency of seizures, and cognitive impairment. Advances in pharmacogenomics may in the future enable such adverse effects to be predicted for individual patients. Meanwhile, a systematic approach to reporting AED‐induced seizure aggravation should be developed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s0012162206000843

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy
Guerrini, R., Dravet, C., Genton, P., Belmonte, A., Kaminska, A., & Dulac†, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01413.x · Cited by 467
Genetic susceptibility to adverse drug reactions
Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01717-x · Cited by 328
A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor
Suzdak, P. D., & Jansen, J. A. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb02576.x · Cited by 278
Atypical Benign Partial Epilepsy of Childhood
Aicardi, J. F., & Chevrie, J. J. (1982) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1982.tb13620.x · Cited by 251
Exacerbation of Seizures in Children by Carbamazepine
Snead, O. C., & Hosey, L. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510103131503 · Cited by 237
Landau‐Kleffner Syndrome: A Pharmacologic Study of Five Cases
Marescaux, C., Hirsch, É., Finck, S., Maquet, P., Schlumberger, É., Sellal, F., Metz‐Lutz, M., Alembik, Y., Salmon, É., Franck, G., et al. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05518.x · Cited by 211
"BALTIC" MYOCLONUS EPILEPSY: HEREDITARY DISORDER OF CHILDHOOD MADE WORSE BY PHENYTOIN
Eldridge, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90749-3 · Cited by 180
Status Epilepticus: Mechanisms of Brain Damage and Treatment
Levy, R. H. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050150030010 · Cited by 160
Tonic Status Epilepticus precipitated by Intravenous Benzodiazepine in Five Patients with Lennox‐Gastaut Syndrome
Tassinari, C. A., Dravet, C., Roger, J., Cano, J. P., & Gastaut, H. (1972) · Epilepsia · doi:10.1111/j.1528-1157.1972.tb04582.x · Cited by 144
Aicardi's Epilepsy in Children
Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00881.x · Cited by 136

Show all 45 references

Research works printed but not linked: 2

Vossler DG, 1996, Exacerbation of seizures in Lennox Gestaut syndrome by Gabapentin, Neurology, 46, 852
Vallarta JM, 1974, Progressive encephalopathy due to chronic hydantoin intoxication, Am J Dis Child, 128, 27

Sorted by citations

Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Löscher, W., & Klein, P. (2021) · CNS Drugs · doi:10.1007/s40263-021-00827-8 · Cited by 393
Computer modelling of epilepsy
Lytton, W. W. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2416 · Cited by 291
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
Rogawski, M. A., Tofighy, A., White, H. S., Matagne, A., & Wolff, C. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.11.021 · Cited by 208
Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Wahab, A. (2010) · Pharmaceuticals · doi:10.3390/ph3072090 · Cited by 160
Reflex seizures, traits, and epilepsies: from physiology to pathology
Koepp, M. J., Caciagli, L., Pressler, R., Lehnertz, K., & Beniczky, S. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00219-7 · Cited by 117
Epilepsy in Rett syndrome—The experience of a National Rett Center
Nissenkorn, A., Gak, E., Vecsler, M., Reznik, H., Menascu, S., & Zeev, B. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02597.x · Cited by 101
The challenges of treating epilepsy with 25 antiepileptic drugs
Santulli, L., Coppola, A., Balestrini, S., & Striano, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.016 · Cited by 97
Treatment of Lennox-Gastaut syndrome: overview and recent findings
van Rijckevorsel, K. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1668 · Cited by 97
Perampanel: Does it have broad‐spectrum potential?
Potschka, H., & Trinka, E. (2018) · Epilepsia · doi:10.1111/epi.14456 · Cited by 90
The medical management of the epilepsies in children: conceptual and practical considerations
Raspall‐Chaure, M., Neville, B. G. R., & Scott, R. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70324-1 · Cited by 75
Methylated flavonoids as anti-seizure agents: Naringenin 4′,7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models
Copmans, D., Orellana-Paucar, A. M., Steurs, G., Zhang, Y., Ny, A., Foubert, K., Exarchou, V., Siekierska, A., Kim, Y., Borggraeve, W. M. D., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.11.011 · Cited by 73
Paradoxical and Bidirectional Drug Effects
Smith, S. W., Hauben, M., & Aronson, J. K. (2012) · Drug Safety · doi:10.2165/11597710-000000000-00000 · Cited by 70
Evolution and management of Lennox‐Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue?
Kerr, M., Kluger, G. J., & Philip, S. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0409 · Cited by 70
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
Talwar, A., Estes, E., Aparasu, R., & Reddy, D. S. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114238 · Cited by 66
A Simple Quantitative Method for Analyzing Electrographic Status Epilepticus in Rats
Lehmkuhle, M. J., Thomson, K. E., Scheerlinck, P. H., Pouliot, W. A., Greger, B. E., & Dudek, F. E. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91062.2008 · Cited by 64
Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy
Guerrini, R., Zaccara, G., la Marca, G., & Rosati, A. (2012) · Drug Safety · doi:10.2165/11630700-000000000-00000 · Cited by 56
Aggravation of Seizures and/or EEG Features in Children Treated with Oxcarbazepine Monotherapy
Vendrame, M., Khurana, D. S., Cruz, M., Melvin, J. J., Valencia, I., Legido, A., & Kothare, S. V. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01210.x · Cited by 53
Pharmacological Activity of Pyrazole Derivatives as an Anticonvulsant for Benefit against Epilepsy
Gao, M., Qu, K., Zhang, W., & Wang, X. (2021) · NeuroImmunoModulation · doi:10.1159/000513297 · Cited by 48
Paradoxical proepileptic response to NMDA receptor blockade linked to cortical interneuron defect in stargazer mice
Maheshwari, A., Nahm, W. K., & Noebels, J. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00156 · Cited by 45
Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial
Ohtsuka, Y., Yoshinaga, H., Shirasaka, Y., Takayama, R., Takano, H., & Iyoda, K. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.002 · Cited by 44
Early Diagnosis and Treatment of Lennox-Gastaut Syndrome
Resnick, T., & Sheth, R. D. (2017) · Journal of Child Neurology · doi:10.1177/0883073817714394 · Cited by 37
Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
Rogawski, M. A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106506 · Cited by 34
Managing Severe Epilepsy Syndromes of Early Childhood
Wheless, J. W. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338153 · Cited by 33
Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results
Massot, A., Vivanco, R. A., Príncipe, A., Roquer, J., & Rocamora, R. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.02.002 · Cited by 31
Estudio postautorización de la eslicarbazepina en el tratamiento de epilepsias farmacorresistentes: resultados preliminares
Massot‐Tarrús, A., Vivanco‐Hidalgo, R. M., Príncipe, A., Roquer, J., & Rocamora, R. (2013) · Neurología · doi:10.1016/j.nrl.2013.02.013 · Cited by 30
Brief Report: Retrospective Case Series of Oxcarbazepine for Irritability/Agitation Symptoms in Autism Spectrum Disorder
Douglas, J. F., Sanders, K. B., Benneyworth, M. H., Smith, J. L., DeJean, V. M., McGrew, S. G., & Veenstra-VanderWeele, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1661-2 · Cited by 30
Drugs that lower the seizure threshold
Hitchings, A. W. (2016) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000016 · Cited by 29
Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors
Booker, S. A., Pires, N. M., Cobb, S., Soares-da-Silva, P., & Vida, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.019 · Cited by 28
Clozapine-induced myoclonus: a case report and review of the literature
Osborne, I. J., & McIvor, R. J. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612015 · Cited by 27
Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE)
Mostacci, B., Ranzato, F., Giuliano, L., Neve, A. L., Aguglia, U., Bilo, L., Durante, V., Ermio, C., Monti, G., Zambrelli, E., et al. (2020) · Seizure · doi:10.1016/j.seizure.2020.12.005 · Cited by 27
Embelin Protects Against Acute Pentylenetetrazole-Induced Seizures and Positively Modulates Cognitive Function in Adult Zebrafish
Kundap, U. P., Choo, B. K. M., Kumari, Y., Ahemad, N., Othman, I., & Shaikh, M. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01249 · Cited by 25
The risk of paradoxical levetiracetam effect is increased in mentally retarded patients
Szűcs, A., Clemens, Z., Jakus, R., Rásonyi, G., Fabó, D., Holló, A., Barcs, G., Kelemen, A., & Janszky, J. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01585.x · Cited by 25
COVID-19 containment and its unrestrained impact on epilepsy management in resource-limited areas of Pakistan
Saleem, T., Sheikh, N., Abbasi, M. H., Javed, I., & Khawar, M. B. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107476 · Cited by 23
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019)
Franco, V., Barbieri, M. A., Cutroneo, P. M., Arena, I. G., Cicala, G., Marchione, P., Spina, E., & Perucca, E. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107989 · Cited by 23
Computational approaches for innovative antiepileptic drug discovery
Talevi, A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1216965 · Cited by 21
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults
Stephen, L. J., & Brodie, M. J. (2020) · CNS Drugs · doi:10.1007/s40263-020-00698-5 · Cited by 20
Non-convulsive status epilepticus in adults - an overview
Rüegg, S. J. (2008) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2008.01928 · Cited by 19
Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions
Tursunov, A. N., Vasilyev, D. S., & Nalivaeva, N. N. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023050228 · Cited by 18
Thalidomide for treatment of refractory epilepsy
Palencia, G., Martínez-Juárez, I. E., Calderón, A., Artigas, C., & Sotelo, J. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.10.003 · Cited by 18
Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: Does risk occur with therapeutic doses?
Melani, F., Rosati, E., Chiocchetti, B., & Muscas, G. C. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.01.018 · Cited by 16
Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
Zaccara, G., Mula, M., Ferrò, B., Consoli, D., Elia, M., Giallonardo, A. T., Iudice, A., Neve, A. L., Meletti, S., Tinuper, P., et al. (2018) · Epilepsia · doi:10.1111/epi.14622 · Cited by 16
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population
D’Onofrio, G., Roberti, R., Riva, A., Russo, E., Verrotti, A., Striano, P., & Belcastro, V. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00344 · Cited by 15
X-Linked Epilepsies: A Narrative Review
Bernardo, P., Cuccurullo, C., Rubino, M., Vita, G. D., Terrone, G., Bilo, L., & Coppola, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074110 · Cited by 14
An international pilot study of an internet‐based platform to facilitate clinical research in epilepsy: The EpiNet project
Bergin, P., Sadleir, L. G., Legros, B., Mogal, Z., Tripathi, M., Dang, N., Beretta, S., Zanchi, C., Burneo, J. G., Borkowski, T. M., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03636.x · Cited by 14
Generalized Myoclonus and Spasticity Induced by Lamotrigine Toxicity
Algahtani, H. A., Aldarmahi, A. A., Al-Rabia, M. W., Almalki, W. H., & Young, G. B. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000020 · Cited by 12
Activity Clamp Provides Insights into Paradoxical Effects of the Anti-Seizure Drug Carbamazepine
Morris, G., Leite, M., Kullmann, D. M., Pavlov, I., Schorge, S., & Lignani, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3697-16.2017 · Cited by 11
Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019
Jin, K., Obara, T., Hirano, K., Hirai, D., Kiuchi, M., Tanaka, T. Q., & Nakasato, N. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108841 · Cited by 11
Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures
Veerapandiyan, A., Singh, P. K., & Mikati, M. A. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0491 · Cited by 11
Particularités de la prise en charge des enfants ayant une épilepsie
Auvin, S. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2010.12.006 · Cited by 11
Principles of Therapy in the Epilepsies
PANAYIOTOPOULOS, C. P. (2010) · Springer eBooks · doi:10.1007/978-0-85729-009-0 · Cited by 10
Reflex seizures induced by micturition and defecation, successfully treated with clobazam and phenytoin
Higuchi, T., Fukuyama, T., Misawa, Y., Inaba, Y., Ichikawa, M., & Koike, K. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0423 · Cited by 10
Principles of therapy in the epilepsies
Panayiotopoulos, C. P. (2010) · Springer eBooks · doi:10.1007/978-1-84628-644-5_7 · Cited by 10
Childhood epilepsies: What should a pediatrician know?
Bashiri, F. A. (2017) · Neurosciences · doi:10.17712/nsj.2017.1.20160244 · Cited by 10
Glutamate transmission rather than cellular pacemaking propels excitatory-inhibitory resonance for ictogenesis in amygdala
Wang, G., Chou, P., Hsueh, S. W., Yang, Y., & Kuo, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105188 · Cited by 9
Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy — A systematic review of the literature using lacosamide as an example
Arzimanoglou, A. A., Kalilani, L., Anamoo, M. A., Cooney, M., Golembesky, A., Taeter, C., Bozorg, A. M., Tofighy, A., & Wheless, J. W. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.05.002 · Cited by 8
Pharmacotherapy of idiopathic generalized epilepsies
Curatolo, P., Moavero, R., Castro, A. L., & Cerminara, C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802618647 · Cited by 7
Principles and Current Issues of Antiepileptic Drug Therapy
Pisani, L. R., Belcastro, V., Oteri, G., & Pisani, F. (2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608057580113010008 · Cited by 6
Anti-seizure medication eslicarbazepine affects the synaptic transmission and plasticity in the rat hippocampal synapses
Rana, Z. S., Pathania, C., Modgil, A., & Punnakkal, P. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.016 · Cited by 5
Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France
Laroche, M., Labetoulle, M., Jouanjus, É., Kröger, E., & Zongo, A. (2025) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70028 · Cited by 5
Aggravation of symptomatic occipital epilepsy of childhood by carbamazepine
Škrijelj, F., & Mulić, M. (2014) · Vojnosanitetski pregled · doi:10.2298/vsp1404404s · Cited by 5
Psychiatric illness and psychotropic medication use in epilepsy
Perr, J. V., & Ettinger, A. B. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977145.016 · Cited by 5
Paradoxical phenomena in epilepsy
Schachter, S. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978098.013 · Cited by 4
Politerapia racional en epilepsia. II. Aspectos clínicos y farmacológicos
Armijo, J. A., & Herranz, J. L. (2007) · Revista de Neurología · doi:10.33588/rn.4503.2007260 · Cited by 4
Seizures exacerbated by antiepileptic drugs in children
Ong, L. C. (2010) · Cited by 4
Suspected induction of epileptic negative myoclonus after lacosamide initiation
Yamamoto, N., Kuki, I., Inoue, T., Yamada, N., Okazaki, S., Shide‐Moriguchi, Y., & Yoshida, S. (2025) · Epilepsia · doi:10.1111/epi.18595 · Cited by 3
Adrenergic mechanisms of absence status epilepticus
Sitnikova, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1298310 · Cited by 3
Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery
Kreir, M., Putri, D., Tekle, F. B., Pibiri, F., d’Ydewalle, C. V. O., Ammel, K. V., Geys, H., Teisman, A. C. H., Gallacher, D. J., & Lu, H. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1308547 · Cited by 4
Seizure Aggravation—Evidence that Oxcarbazepine Requires Monitoring
Ben‐Menachem, E. (2008) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.00252.x · Cited by 3
Seizure aggravation caused by antiepileptic drugs in a patient with muscle–eye–brain disease
Belcastro, V., Galletti, F., Giuglietti, M., Messina, S., Elia, M., Prontera, P., & Calabresi, P. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.09.010 · Cited by 3
Encefalopatía reversible por ácido valproico en un adolescente con epilepsia generalizada idiopática
Raspall‐Chaure, M., Samper, E. L., Toledo, M., Salas‐Puig, J., Macaya, A., & Roig-Quilis, M. (2012) · Revista de Neurología · doi:10.33588/rn.5511.2012374 · Cited by 2
Seizures, medical child abuse, and the pediatric neurologist
Goulbourne, M., & Huber, C. M. (2024) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2024.101137 · Cited by 2
Medication-Induced Seizures and Status Epilepticus
Zutshi, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-31230-9_22 · Cited by 2
Carbamazepine-induced seizure in a nonepileptic child
Benny, R., Bolegave, V., Sadawarte, S., & Khatav, V. (2017) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_169_17 · Cited by 2
Pharmacovigilance of unlicensed cannabidiol in European countries
Calapai, F., Esposito, E., Ammendolia, I., Mannucci, C., Calapai, G., Currò, M., Cardia, L., & Chinou, İ. (2023) · Phytotherapy Research · doi:10.1002/ptr.8028 · Cited by 3
Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions
Tursunov, A. N., Vasilyev, D. S., & Nalivaeva, N. N. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923100126 · Cited by 2
Drug-Induced Seizures in Critically Ill Patients
Rhoney, D. H., & Varelas, P. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-532-3_13 · Cited by 2
Electroencephalogram in unilateral multilobar polymicrogyria with nonconvulsive status epilepticus
Martinović, Ž., & Jović, N. (2007) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2007.05.009 · Cited by 2
EFFICACY AND TOLERABILITY OF LEVETIRACETAM (KEPPRA®) IN THE TREATMENT OF EPILEPSY: REVIEW OF LITERATURE
Мukhin, К. Y., & Пылаева, О. А. (2015) · Russian Journal of Child Neurology · doi:10.17650/2073-8803-2015-10-2-38-53 · Cited by 2
Objectifs et aspects pratiques des médicaments antiépileptiques
Auvin, S. (2015) · Soins Pédiatrie/Puériculture · doi:10.1016/j.spp.2015.01.003 · Cited by 1
Management of Idiopathic Generalized Epilepsies
Ferrie, C. D. (2010) · Springer eBooks · doi:10.1007/978-1-84882-128-6_156 · Cited by 1
Lacosamide Reduces Seizure Severity but Increases Seizure Frequency in PTZ-Kindled Rats
Gáll, Z., Koncz, S., Gáll, O., & Kolcsár, M. (2017) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2017-0037 · Cited by 1
Inducción de crisis de ausencia atípica durante el tratamiento con perampanel
Rodríguez, A. D., Extremera, V. C., Fernández, M. G., Peñas, J. J. G., & Rojas, M. L. R.-F. (2019) · Anales de Pediatría · doi:10.1016/j.anpedi.2019.01.015 · Cited by 1
Drug-Induced Seizures in Critically Ill Patients
Rhoney, D. H., & Shepherd, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-49557-6_20 · Cited by 1
Antiepilépticos
Auvin, S. (2014) · EMC - Pediatría · doi:10.1016/s1245-1789(14)67013-x · Cited by 1
Induced atypical absence seizures during treatment with perampanel
Rodríguez, A. D., Extremera, V. C., Fernández, M. G., Peñas, J. J. G., & Rojas, M. L. R.-F. (2019) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2019.01.014 · Cited by 1
Management of Childhood Epilepsy Syndromes
Ferrie, C. D. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch14 · Cited by 1
Management of Epilepsy in People with Intellectual Disabilities
Brodtkorb, E. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch15 · Cited by 1
Medikamentöse Langzeittherapie von Epilepsien
Neubauer, B. A., & Hahn, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-41954-6_19
Conceptos básicos de la epilepsia infantil
Díaz, R. A. S. (2008) · Neurología
Dramatic Aggravation of Partial Seizures Induced by Gabapentin Overdose
Kobayashi, K., Takeuchi, A., Oka, M., Endoh, F., Yoshinaga, H., & Ohtsuka, Y. (2008) · Epilepsy & Seizure · doi:10.3805/eands.1.40
THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
Мukhin, К. Y., & Пылаева, О. А. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17650/2073-8803-2014-9-2-30-31
Outcome of pediatric epilepsies in adulthood
Gourfinkel‐An, I., & Dubeau, F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00084-1
Best Practices in Neurological Care
Ovbiagele, B. (2014) · doi:10.2217/9781780842790
Epilepsy and epilepsy-related behaviour disorders among people with intellectual disability
Iivanainen, M. V. (2012) · doi:10.1093/med/9780199696758.003.0247
Optimización del tratamiento
Viteri, C. (2009)
Rufinamide in patients with Lennox-Gastaut syndrome
Clark, P. O., & Gibson, P. A. (2016) · Nursing Research and Reviews · doi:10.2147/nrr.s116114
Neurophysiological and pharmacological study of carbamazepine on physiological and pathological GABAergic-dependent thalamocortical oscillations
Zheng, T. W. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Seizure Aggravation Following Adjunctive Levetiracetam Therapy in Children with Epilepsy: a Single Tertiary Center Experience
김영미, 남상욱, Min, Y. G., 이윤진, 윤리라, & 공주현 (2017) · Annals of Child Neurology · doi:10.26815/jkcns.2017.25.3.139
Anticonvulsant Agents: Pharmacology and Biochemistry
Löscher, W. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_466-1

Authors: Gayatri, N., & Livingston, J.
Affiliations: Leeds Teaching Hospitals NHS Trust (GB)
Corresponding author: Gayatri, NA
Venue: Developmental Medicine & Child Neurology
Publisher: Wiley
Published: 2006-05
Volume: 48
Issue: 5
Pages: 394-398
ISSN: 0012-1622 (ISSN-L)
1469-8749
DOI: 10.1017/s0012162206000843
OpenAlex: W2150292807
Cited by: 114
References: 45
Citations by year: 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 9 · 2016: 5 · 2015: 8 · 2014: 10 · 2013: 4 · 2012: 8
FWCI: 0.83
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 305 d)
Locations: Developmental Medicine & Child Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: antiepileptic drugs, adverse drug reactions, carbamazepine, idiopathic generalized epilepsy, myoclonic epilepsy, valproic acid, status epilepticus, paradoxical drug reaction, drug-induced encephalopathy, pharmacogenomics, risk factors, seizure frequency
MeSH terms: Anticonvulsants, Child, Epilepsy, Humans, Severity of Illness Index, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aggravation of epilepsy by anti-epileptic drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks